NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Transcranial Magnetic Stimulation (TMS) Therapy at Countryside Neurology
Welcome to Countryside Neurology, your premier TMS Therapy provider in Palm Harbor, Florida, serving the greater Tampa Bay area. What [...]
Unveiling Tourette Syndrome: Exploring Innovative Treatment with TMS Therapy
Tourette Syndrome (TS) is a neurological condition characterized by repetitive, involuntary movements and vocalizations known as tics. While it typically [...]
TMS Therapy for Tic Disorder: Restoring Control and Confidence
Tic disorders, characterized by sudden, repetitive movements or sounds, can significantly impact daily life. While medications and therapy are traditional [...]
TMS Therapy for Tic Disorders
Are you or a loved one struggling with tic disorders, experiencing the disruptive and involuntary movements or vocalizations that characterize [...]
TMS Therapy: A New Hope for Addiction and Binge Eating at Countryside Neurology
Addiction and binge eating can have a significant impact on an individual's physical health, emotional well-being, and relationships. Finding effective [...]
TMS Therapy for Binge Eating at Countryside Neurology: A New Approach to Treating Binge Eating Disorder
Binge Eating Disorder (BED) is a serious condition that affects millions of people worldwide. It's characterized by recurrent episodes of [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social